Basaloid squamous cell carcinoma of the head and neck

被引:0
|
作者
Paulino, AFG
Singh, B
Shah, JP
Huvos, AG
机构
[1] Univ Michigan Hosp, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源
LARYNGOSCOPE | 2000年 / 110卷 / 09期
关键词
basaloid squamous cell carcinoma; head and neck;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective/Hypothesis: Basaloid squamous cell carcinoma (BSCC), an uncommon tumor with predilection for the upper aerodigestive tract, is a distinct variant of squamous carcinoma, because of its unique histological features and ominous clinical behavior. This study reviews the experience in treating BSCC from two institutions. Study Design: Retrospective. Methods: H&E-stained sections from 20 patients with BSCC of the head and neck were reviewed and clinical follow-up was obtained for all patients. Results: The study group consisted of 14 male and 6 female patients. Their ages ranged from 43 to 85 years, with a mean age of 62 years. Sites of origin included the larynx (4), tongue (3), pyriform sinus (3), nose (2), floor of mouth (2), mastoid (1), tonsil (1), epiglottis (1), nasopharynx (1), trachea (1), and palate (1), Pain was the most common presenting symptom (5 cases), followed by hoarseness and bleeding (3 cases each). Tobacco and alcohol abuse was noted in 17 patients. Treatment modalities included surgery with or without chemotherapy or radiotherapy in 13 patients, chemotherapy with irradiation in 2, chemotherapy alone in 2, and radiotherapy alone in 3, Clinical follow-up revealed no evidence of disease in 11 patients. Four were alive with disease at the time of writing and five died of disease. Conclusion: BSCC is a highly aggressive malignant tumor that presents in elderly patients who have a history of abuse of tobacco or alcohol, or both. Greater number of patients must be studied and compared with age-matched and stage-matched controls of conventional squamous cell carcinoma to determine whether the poor clinical outcome is related more to high-stage presentation or to the tumor's high-grade malignant cytological features.
引用
收藏
页码:1479 / 1482
页数:4
相关论文
共 50 条
  • [41] Course and prognosis of basaloid squamous cell carcinoma of the head and neck: A case-control study of 62 patients
    Soriano, Edouard
    Faure, Claire
    Lantuejoul, Sylvie
    Reyt, Emile
    Bolla, Michel
    Brambilla, Elisabeth
    Righini, Christian A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (02) : 244 - 250
  • [42] Identification of Human Papilloma Virus (HPV) in Basaloid Squamous Cell Carcinoma of the Head and Neck and Its Clinicopathologic Significance
    Chernock, R. D.
    Lewis, J. S., Jr.
    El-Mofty, S. K.
    MODERN PATHOLOGY, 2009, 22 : 246A - 246A
  • [43] Basaloid squamous cell carcinoma clinically and radiologically masquerading as a head and neck paraganglioma: a case report and review of the literature
    Weerasekara, Pumudu
    Chandrarathne, Nadeeka
    Jayaweera, Geethika
    Rathnayake, Wasantha
    Perera, Sunil
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [44] Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck
    Jacobi, Christian
    Ayx, Isabelle
    Fritsche, Kristin
    Piontek, Guido
    Hoffmann, Dieter
    Weirich, Gregor
    Knopf, Andreas
    ONCOTARGET, 2015, 6 (05) : 3462 - 3470
  • [45] Identification of Human Papilloma Virus (HPV) in Basaloid Squamous Cell Carcinoma of the Head and Neck and Its Clinicopathologic Significance
    Chernock, R. D.
    Lewis, J. S.
    El-Mofty, S. K.
    LABORATORY INVESTIGATION, 2009, 89 : 246A - 246A
  • [46] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [47] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [49] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [50] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81